Increased HSP90B1 expression has been shown to be an indicator of poor prognosis in patients with lung cancer [52], chronic lymphocytic leukemia [53], bladder cancer [54], and liver cancer [55]. This evidence concerns the gene HSP90B1 and B-cell chronic lymphocytic leukemia.